Primary	O
outcome	O

The	O
primary	O
outcome	O
was	O
the	O
time	B-PrimaryOutcome
to	I-PrimaryOutcome
clinical	I-PrimaryOutcome
improvement	I-PrimaryOutcome
,	O
defined	O
as	O
the	O
time	B-OutcomeDefinition
from	I-OutcomeDefinition
enrollment	I-OutcomeDefinition
to	I-OutcomeDefinition
an	I-OutcomeDefinition
improvement	I-OutcomeDefinition
of	I-OutcomeDefinition
two	I-OutcomeDefinition
points	I-OutcomeDefinition
on	I-OutcomeDefinition
a	I-OutcomeDefinition
seven	I-OutcomeDefinition
-	I-OutcomeDefinition
category	I-OutcomeDefinition
ordinal	I-OutcomeDefinition
scale33	I-OutcomeDefinition
(	I-OutcomeDefinition
Supplementary	I-OutcomeDefinition
Table	I-OutcomeDefinition
4	I-OutcomeDefinition
)	I-OutcomeDefinition
or	I-OutcomeDefinition
live	I-OutcomeDefinition
discharge	I-OutcomeDefinition
from	I-OutcomeDefinition
the	I-OutcomeDefinition
hospital	I-OutcomeDefinition
,	I-OutcomeDefinition
whichever	I-OutcomeDefinition
came	I-OutcomeDefinition
first	I-OutcomeDefinition
.	O

Secondary	O
outcomes	O

Secondary	O
outcomes	O
included	O
the	O
time	B-SecondaryOutcome
to	I-SecondaryOutcome
radiological	I-SecondaryOutcome
improvement	I-SecondaryOutcome
defined	O
as	O
the	O
time	B-OutcomeDefinition
from	I-OutcomeDefinition
enrollment	I-OutcomeDefinition
to	I-OutcomeDefinition
radiological	I-OutcomeDefinition
improvement	I-OutcomeDefinition
on	I-OutcomeDefinition
chest	I-OutcomeDefinition
CT	I-OutcomeDefinition
scans	I-OutcomeDefinition
,	O
the	O
time	O
to	O
virus	O
nucleic	O
acid	O
negative	O
conversion	O
defined	O
as	O
the	O
time	O
from	O
enrollment	O
to	O
two	O
consecutive	O
negative	O
tests	O
for	O
SARS	O
-	O
CoV	O
-	O
2	O
via	O
qRT	O
-	O
PCR	O
on	O
nasopharyngeal	O
swabs	O
samples	O
,	O
the	O
overall	O
rate	O
of	O
clinical	O
improvement	O
assessed	O
on	O
day	O
28	O
.	O

Safety	O
outcomes	O
included	O
treatment	B-OtherOutcome
-	I-OtherOutcome
emergent	I-OtherOutcome
AEs	I-OtherOutcome
and	I-OtherOutcome
SAEs	I-OtherOutcome
,	I-OtherOutcome
classified	I-OtherOutcome
according	I-OtherOutcome
to	I-OtherOutcome
the	I-OtherOutcome
National	I-OtherOutcome
Cancer	I-OtherOutcome
Institute	I-OtherOutcome
Common	I-OtherOutcome
Terminology	I-OtherOutcome
Criteria	I-OtherOutcome
for	I-OtherOutcome
Adverse	I-OtherOutcome
Events	I-OtherOutcome
,	I-OtherOutcome
version	I-OtherOutcome
4	I-OtherOutcome
.	I-OtherOutcome
0	I-OtherOutcome
.	O

AEs	O
and	O
SAEs	O
were	O
assessed	O
and	O
recorded	O
once	B-TimeFrame
daily	I-TimeFrame
by	I-TimeFrame
trained	I-TimeFrame
researchers	I-TimeFrame
from	I-TimeFrame
day	I-TimeFrame
0	I-TimeFrame
to	I-TimeFrame
day	I-TimeFrame
28	I-TimeFrame
.	O

Other	O
secondary	O
outcomes	O
included	O
overall	B-SecondaryOutcome
rates	I-SecondaryOutcome
of	I-SecondaryOutcome
radiological	I-SecondaryOutcome
improvement	I-SecondaryOutcome
on	B-TimeFrame
days	I-TimeFrame
7	I-TimeFrame
,	I-TimeFrame
14	I-TimeFrame
,	I-TimeFrame
and	I-TimeFrame
28	I-TimeFrame
on	B-OutcomeDefinition
chest	I-OutcomeDefinition
CT	I-OutcomeDefinition
scans	I-OutcomeDefinition
,	O
overall	B-SecondaryOutcome
rates	I-SecondaryOutcome
of	I-SecondaryOutcome
virus	I-SecondaryOutcome
nucleic	I-SecondaryOutcome
acid	I-SecondaryOutcome
negative	I-SecondaryOutcome
conversion	I-SecondaryOutcome
via	I-SecondaryOutcome
qRT	I-SecondaryOutcome
-	I-SecondaryOutcome
PCR	I-SecondaryOutcome
on	I-SecondaryOutcome
nasopharyngeal	I-SecondaryOutcome
swabs	I-SecondaryOutcome
samples	I-SecondaryOutcome
on	B-TimeFrame
days	I-TimeFrame
7	I-TimeFrame
,	I-TimeFrame
14	I-TimeFrame
,	I-TimeFrame
and	I-TimeFrame
28	I-TimeFrame
,	O
and	O
the	O
rates	B-SecondaryOutcome
of	I-SecondaryOutcome
deterioration	I-SecondaryOutcome
or	I-SecondaryOutcome
death	I-SecondaryOutcome
on	B-TimeFrame
day	I-TimeFrame
28	I-TimeFrame
.	O

